NAD+ Supplements: Forms, Precursors, and Label Guide

NAD+ stands for nicotinamide adenine dinucleotide. It participates in redox reactions that help cells transfer energy and is also used by enzymes involved in cellular signaling and DNA repair-related pathways. The body can make NAD from vitamin B3-related precursors; this is one reason NAD language appears across several different supplement ingredients. ¹

Biological importance does not establish that swallowing a product labeled NAD+ will deliver the intact molecule to a particular tissue, correct a deficiency, improve energy, or change aging. Those are separate questions that require preparation-specific human evidence.

NR and NMN are often presented as interchangeable alternatives, but their label forms and study context should remain separate. See the focused guide to NMN versus NR for a direct comparison.

Direct NAD+ products may be sold as capsules, powders, liquids, lozenges, liposomal preparations, sublingual tablets, or nasal sprays. These words can identify a meaningful product difference, but they do not establish a fixed absorption advantage. Evidence from one proprietary preparation should not be transferred to every product using the same broad delivery term.

Randomized human studies show that NR and NMN can increase circulating NAD-related measures under specific conditions. A six-week crossover study used 1,000 mg per day of NR in 24 middle-aged and older adults, while a 2026 head-to-head study in 65 healthy adults found that 14 days of NR and NMN, but not nicotinamide, comparably increased circulating NAD+. ^{3 4 5}

These studies support ingredient-specific biomarker statements. They do not show that direct NAD+, NADH, NR, NMN, and niacinamide are interchangeable, or that increasing a blood measure proves more energy, better cognition, disease treatment, or slower aging.

Direct oral NAD+ evidence is emerging. A 2026 company-funded, non-peer-reviewed preprint reported a randomized trial in 60 adults, with 50 included in the primary analysis, using 2,000 mg per day for five days of one proprietary oral NAD+ formulation. Intracellular NAD measured in whole blood increased, while plasma NAD did not change. The study was short, retrospectively registered, and secondary clinical laboratory, vital-sign, and wellbeing signals did not remain significant after correction for multiple comparisons. It cannot validate ordinary NAD+ capsules or establish a health outcome. ⁶

A 2026 Nature Metabolism study used a validated measurement method across seven independent human cohorts and found that whole-blood NAD+ remained stable with age and across the lifestyle interventions examined. The researchers concluded that whole-blood NAD+ has limited utility as a biomarker of aging or lifestyle factors. ²

This finding does not mean that NAD biology is unimportant or that every tissue behaves identically. It means a front-label claim that everyone’s NAD+ inevitably falls with age is too broad. Blood, specific cell populations, muscle, brain, and other tissues are not interchangeable measurement compartments. For a closer look at the study, read Does NAD+ Really Decline With Age?

NAD+ (nicotinamide adenine dinucleotide), 100 mg

This is a directly disclosed NAD+ amount per serving. It should be evaluated as direct NAD+, not as 100 mg of NR, NMN, or NADH.

Liposomal NAD+, 250 mg

The label identifies direct NAD+ and a delivery claim. Unless the label says otherwise, 250 mg remains the disclosed NAD+ amount, not a multiplied “effective dose” or proof of improved absorption.

Nicotinamide riboside chloride, 300 mg

This is an NR precursor product. Its study context belongs to NR, and the 300 mg should not be presented as 300 mg of direct NAD+.

NAD booster proprietary blend, 500 mg total

If NAD+, NR, NMN, and Resveratrol are listed without individual amounts, 500 mg belongs to the full blend. The contribution of each component remains unknown.

Direct oral NAD+ does not have a broadly established supplement upper limit or a mature long-term safety evidence base. NR, NMN, NADH, niacin, and niacinamide have different evidence and safety contexts, so tolerability from one should not be transferred to another.

Pregnancy, breastfeeding, medication use, active medical treatment, or a medical condition warrant individual review with a qualified clinician or pharmacist. A label analysis cannot provide complete interaction clearance or decide whether manipulating an NAD-related pathway is appropriate for a particular person.

NAD+ infusions and injections are medical-style interventions rather than ordinary dietary supplements. Route, sterility, dose, infusion rate, adverse effects, and supervision require separate clinical evaluation.